News Chart MIRA Pharmaceuticals, Inc.

Equities

MIRA

US60458C1045

Market Closed - Nasdaq Other stock markets 21:00:00 01/07/2024 BST			5-day change	1st Jan Change
0.659 ^USD	+3.45%		-7.20%	-37.24%

06-24	MIRA Pharmaceuticals, Inc. Announces Ketamir-2 Shows Promising Safety Profile in Comparison to Traditional Ketamine In Preclinical Testing	CI
06-10	MIRA Pharmaceuticals, Inc. Announces Positive Preclinical Study Results for Its Novel Oral Ketamine Analog, Ketamir-2, Paving the Way for IND Submission Later This Year	CI

0faa6d6d86b7dc.LTiYJL08gLhuSwdbU63GjnFM3vWq4u9g092NkUZUEVY.bHWvQMxt0dIhP1YwEtm-vQgI7Zn1qqASoaX74CEHemMdCvdJ01_V1ygydA~6c34f44b56f20834b5c4a423d455d98f